Interleukin 5

 Interleukin 5 (IL5) is an interleukin produced by type-2 T helper cells and mast cells.

IL5
IL5 Crystal Structure.rsh.png
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesIL5, EDF, IL-5, TRF, interleukin 5
External IDsOMIM147850 MGI96557 HomoloGene679 GeneCardsIL5
Gene location (Human)
Chromosome 5 (human)
Chr.Chromosome 5 (human)[1]
Chromosome 5 (human)
Genomic location for IL5
Genomic location for IL5
Band5q31.1Start132,541,445 bp[1]
End132,556,838 bp[1]
RNA expression pattern
PBB GE IL5 207952 at fs.png
More reference expression data
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_000879

NM_010558

RefSeq (protein)

NP_000870

NP_034688

Location (UCSC)Chr 5: 132.54 – 132.56 MbChr 11: 53.72 – 53.73 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

FunctionEdit

Through binding to the interleukin-5 receptor, interleukin 5 stimulates B cell growth and increases immunoglobulin secretion - primarily IgA. It is also a key mediator in eosinophil activation.

StructureEdit

IL-5 is a 115-amino acid (in human, 133 in the mouse) -long TH2 cytokine that is part of the hematopoietic family. Unlike other members of this cytokine family (namely interleukin 3 and GM-CSF), this glycoprotein in its active form is a homodimer.[5]

Tissue expressionEdit

The IL-5 gene is located on chromosome 11 in the mouse, and chromosome 5 in humans, in close proximity to the genes encoding IL-3IL-4, and granulocyte-macrophage colony-stimulating factor (GM-CSF),[6][7] which are often co-expressed in TH2 cells. Interleukin-5 is also expressed by eosinophils[8] and has been observed in the mast cells of asthmatic airways by immunohistochemistry.[9] IL-5 expression is regulated by several transcription factors including GATA3.[10]

Clinical significanceEdit

Interleukin-5 has long been associated with the cause of several allergic diseases including allergic rhinitis and asthma, wherein a large increase in the number of circulating, airway tissue, and induced sputum eosinophils have been observed.[11] Given the high concordance of eosinophils and, in particular, allergic asthma pathology, it has been widely speculated that eosinophils have an important role in the pathology of this disease.[12]

Drugs that target IL-5 are mepolizumab and reslizumab.

Effect on eosinophilsEdit

Eosinophils are terminally differentiated granulocytes found in most mammals. The principal role of these cells, in a healthy host, is the elimination of antibody bound parasites through the release of cytotoxic granule proteins.[13] Given that eosinophils are the primary IL-5Rα-expressing cells, it is not surprising that this cell type responds to IL-5. In fact, IL-5 was originally discovered as an eosinophil colony-stimulating factor,[14] is a major regulator of eosinophil accumulation in tissues, and can modulate eosinophil behavior at every stage from maturation to survival. Mepolizumab is a monoclonal antibody against IL-5 which can reduce excessive eosinophilia.

In Hodgkin lymphoma, for instance, the typically-observed eosinophilia is thought to be attributable to an increased production of IL-5.[15]

InteractionsEdit

Interleukin 5 has been shown to interact with Interleukin 5 receptor alpha subunit.[16][17][18]

This article uses material from the Wikipedia article
 Metasyntactic variable, which is released under the 
Creative Commons
Attribution-ShareAlike 3.0 Unported License
.